Natural Therapies for Ocular Disorders Part Two:<BR>Cataracts and Glaucoma
 
   

Natural Therapies for Ocular Disorders Part Two:
Cataracts and Glaucoma

This section is compiled by Frank M. Painter, D.C.
Send all comments or additions to:   Frankp@chiro.org
 
   

Alternative Medicine Review 2001 (Apr);   6 (2):   141–166 ~ FULL TEXT

Kathleen A. Head, ND


Introduction

Part one of this article was published in the October 1999 issue of Alternative Medicine Review and discussed nutritional and botanical approaches to conditions of the retina. This second part covers alternative treatments for nonretinal disorders: senile cataracts, diabetic cataracts, and chronic open-angle glaucoma.

A large percentage of blindness in the world is nutritionally preventable. 1 The author of this comment was referring primarily to the use of vitamin A to prevent corneal degeneration associated with a vitamin A deficiency; however, there is considerable evidence that many other eye conditions, which are leading causes of vision impairment and blindness, also may be preventable with nutritional supplementation, botanical medicines, diet, and other lifestyle changes. In addition, a number of nutrients hold promise for the treatment of already existing cataracts and glaucoma.


Senile Cataracts

Senile cataracts are the leading cause of impaired vision in the United States, with a large percentage of the geriatric population exhibiting some signs of the lesion. Over one million cataract surgeries are performed yearly in this country alone. 2 Cataracts are developmental or degenerative opacities of the lens of the eye, generally characterized by a gradual painless loss of vision. The extent of the vision loss depends on the size and location of the cataract. Cataracts may be located in the center of the lens (nuclear), in the superficial cortex (cortical), or in the posterior subcapsular area. Cataracts are also classified according to their color, which is consistent with location and density of the cataract. Pale yellow cataracts are typically slight opacities of the cortex, subcapsular region, or both; yellow or light brown cataracts are consistent with moderate to intense opacities of the cortex, nucleus, or both; and brown cataracts are associated with dense nuclear cataracts. 3


Diagnosis

Symptoms include near vision image blur, abnormal color perception, monocular diplopia, glare, and impaired visual acuity, and may vary depending on location of the cataract. For example, if the opacity is located in the center of the lens (nuclear cataract), myopia is often a symptom, whereas posterior subcapsular cataracts tend to be most noticeable in bright light. 4 Ophthalmoscopic examination is best conducted on a dilated pupil, holding the scope approximately one foot away. Small cataracts appear as dark defects against the red reflex, whereas a large cataract may completely obliterate the red reflex. Once a cataract has been established, a referral for slit-lamp examination, which provides more detail on location and extent of opacity, is recommended.


Specific Nutrients and Prevention of Cataracts

Oxidation of lens proteins is part of the pathophysiology of cataracts. Therefore, it is no surprise that antioxidants may help prevent the formation of cataracts.

Carotenes and Vitamin A: Epidemiological Evidence

Levels of nutrients, including carotenoids, have been examined in human cataractous lenses after extraction using high performance liquid chromatography. Vitamins A and E and the carotenoids lutein and zeaxanthin were found. The newer, epithelial/outer cortex layer had more carotenoids, tocopherol, and retinol (approximately 3-, 1.8-, and 1.3-fold higher, respectively) than the older, inner cortex/nuclear portion.20 Other studies have quantified significant levels of lutein, zeaxanthin, and alpha- and gamma-tocopherol in the lens. 21

A prospective study of the effect of carotenes and vitamin A on the risk of cataract formation was conducted as part of the Nurses' Health Study. A total of 77,466 female nurses, ages 45-71 years, were included in the study, which involved food-frequency questionnaires over a 12-year period. After other risk factors were controlled for, including smoking and age, those in the highest quintile for consumption of lutein and zeaxanthin had a 22-percent decreased risk of cataract extraction compared with those in the lowest quintile. 22

Another cohort of the Nurses' Health Study followed 50,823 women, ages 45-67, for eight years and found women in the highest quintile of vitamin A consumption had a 39-percent lower risk of developing cataracts compared to women in the lowest quintile. 23

In a similar study of male health professionals in the United States, 36,644 participants, ages 45-75 years, were followed for eight years with periodic dietary questionnaires. Men in the highest quintile for lutein and zeaxanthin intake had a 19-percent decreased risk of cataract extraction when smoking, age, and other risk factors were controlled for. 24 Neither the women nor the men demonstrated a decreased risk of cataract with intakes of other carotenoids (a-carotene, b-carotene, lycopene, or beta-cryptoxanthin). It is hypothesized the protective effect of the carotenoids may be due to quenching reactive oxygen species generated by exposure to ultraviolet light. 25

The Beaver Dam Eye Study examined risk for developing nuclear cataracts in 252 subjects who were followed over a five-year period. Only a trend toward an inverse relationship between serum lutein and cryptoxanthin and risk of cataract development was noted. 26

Vitamin E: Animal, Epidemiological, and Clinical Studies

As a fat-soluble antioxidant, it is reasonable to predict a positive role for vitamin E as a cataract preventive in the lens cell membrane. Animal, epidemiological, and clinical studies help confirm this hypothesis. A placebo-controlled animal study found 100 IU d-alpha-tocopherol injected subcutaneously prevented ionizing radiation damage to the lens, which did occur in rats not supplemented with vitamin E. 27 Two other animal studies using vitamin E instilled in the eyes as drops confirmed the preventive effect of vitamin E, at least when used topically. 28,29

Several human studies have found low levels of vitamin E intake are associated with increased risk for cataract development. An epidemiological investigation examined self-reported supplementary vitamin consumption of 175 cataract patients compared to 175 matched individuals without cataracts. The cataract-free group used significantly more vitamin E (p=0.004) and vitamin C (p=0.01) than the cataract group, resulting in at least a 50-percent reduction in cataract risk in the supplemented group. 30 An Italian study compared 207 patients with cataracts to 706 control subjects in a hospital setting. Vitamin E, in addition to a number of other nutritional factors, was associated with a decreased risk for cataract. 8

The Vitamin E and Cataract Prevention Study (VECAT) is a four-year, prospective, randomized, controlled trial of vitamin E versus placebo for cataract prevention in a population of healthy volunteers, ages 55-80 years. 31 Although results are still pending, data was collected on prior use of vitamin E and incidence of cataract in 1,111 participants. A statistically significant relationship was found between past vitamin E supplementation and prevention of cortical cataract but not nuclear cataract. 32

The Lens Opacities Case-Control Study was designed to determine risk factors for cataracts in 1,380 participants, ages 40-79 years. Blood chemistry and levels of vitamin E and selenium were performed on all patients. The risk of developing cataracts was reduced to less than one-half (odds ratio 0.44 for nuclear cataracts) in subjects with higher levels of vitamin E. 33 Some of these same researchers examined the association between antioxidants and the risk of cataract in the Longitudinal Study of Cataract. Dietary intake, use of supplements, and plasma vitamin E levels were assessed on 764 participants. Lens opacities were examined on a yearly basis and the risk of development of cataract was 30-percent less in regular users of a multiple vitamin, 57-percent less in regular users of supplemental vitamin E, and 42-percent less is those with higher plasma levels of vitamin E. 34

In a randomized trial of 50 patients with early cataracts, subjects were assigned to receive either 100 mg vitamin E twice daily or placebo for 30 days. There was a significantly smaller increase in the size of cortical cataracts in the vitamin E group compared to placebo. While increases of vitamin E were found in both nuclear and cortical lens homogenates after surgical removal, GSH levels were increased significantly only in those with cortical cataracts receiving vitamin E. In addition, the malondialdehyde (MDA) Ñ a measure of oxidative stress Ñ levels and glutathione peroxidase levels were higher in cortical cataract/vitamin E users than in the nuclear cataract/vitamin E group. 35 Some conclusions that can be drawn from this study are: (1) vitamin E decreases oxidative stress in cataractous lenses; (2) part of vitamin E's protective effect is due to enhancement of GSH levels; and (3) vitamin E seems to be more protective for cortical than nuclear cataracts, at least in this short-term study.

Read the FULL TEXT Article


[SWIRL 2]


Return to the LYCOPENE Page


Return to the CAROTENOIDS Page


Return to the ANTIOXIDANTS Page


Return to the CHIROPRACTIC AND BLINDNESS Page

Since 5-01-2001

           © 2008    The Chiropractic Resource Organization    All Rights Reserved